Tadao Funato

2.3k total citations
89 papers, 1.7k citations indexed

About

Tadao Funato is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Tadao Funato has authored 89 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 20 papers in Oncology and 14 papers in Immunology. Recurrent topics in Tadao Funato's work include RNA and protein synthesis mechanisms (13 papers), Acute Myeloid Leukemia Research (9 papers) and Drug Transport and Resistance Mechanisms (9 papers). Tadao Funato is often cited by papers focused on RNA and protein synthesis mechanisms (13 papers), Acute Myeloid Leukemia Research (9 papers) and Drug Transport and Resistance Mechanisms (9 papers). Tadao Funato collaborates with scholars based in Japan, United States and Australia. Tadao Funato's co-authors include Kevin J. Scanlon, Mohammed Kashani–Sabet, T Tone, Lu Jiao, Mitsuo Kaku, Takeshi Sasaki, John J. Rossi, Øystein Fodstad, Takeshi Sasaki and Viví Ann Flørenes and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.

In The Last Decade

Tadao Funato

86 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tadao Funato Japan 23 973 458 264 189 151 89 1.7k
Lotte K. Vogel Denmark 27 772 0.8× 485 1.1× 311 1.2× 158 0.8× 292 1.9× 59 2.0k
Alfredo A. Molinolo United States 20 672 0.7× 562 1.2× 213 0.8× 188 1.0× 293 1.9× 30 1.6k
Salvador F. Aliño Spain 25 1.1k 1.1× 364 0.8× 496 1.9× 192 1.0× 212 1.4× 112 1.9k
William C. Hyun United States 25 753 0.8× 192 0.4× 128 0.5× 199 1.1× 148 1.0× 46 1.7k
Hongmin Chen United States 19 786 0.8× 282 0.6× 206 0.8× 398 2.1× 160 1.1× 33 1.6k
Tadashi Osaki Japan 20 647 0.7× 377 0.8× 144 0.5× 604 3.2× 126 0.8× 44 1.6k
John A. Feild United States 16 905 0.9× 405 0.9× 341 1.3× 181 1.0× 275 1.8× 24 1.5k
Noriko Hosoya Japan 22 1.2k 1.2× 353 0.8× 435 1.6× 167 0.9× 271 1.8× 53 2.2k
Gerald J. Mizejewski United States 27 1.3k 1.4× 590 1.3× 375 1.4× 303 1.6× 334 2.2× 120 2.6k
C. Khanna United States 21 790 0.8× 516 1.1× 396 1.5× 234 1.2× 347 2.3× 32 2.0k

Countries citing papers authored by Tadao Funato

Since Specialization
Citations

This map shows the geographic impact of Tadao Funato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tadao Funato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tadao Funato more than expected).

Fields of papers citing papers by Tadao Funato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tadao Funato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tadao Funato. The network helps show where Tadao Funato may publish in the future.

Co-authorship network of co-authors of Tadao Funato

This figure shows the co-authorship network connecting the top 25 collaborators of Tadao Funato. A scholar is included among the top collaborators of Tadao Funato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tadao Funato. Tadao Funato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamamoto, Yasuko, Katsuya Okawa, Tadao Funato, et al.. (2013). Acquired resistance of leukemic cells to AraC is associated with the upregulation of aldehyde dehydrogenase 1 family member A2. Experimental Hematology. 41(7). 597–603.e2. 16 indexed citations
2.
Funato, Tadao, et al.. (2002). Microsatellite instability in gonadal tumors of XY pure gonadal dysgenesis patients. International Journal of Gynecological Cancer. 12(2). 192–197. 3 indexed citations
3.
Haginoya, Kazuhiro, Toshihiro Ohura, Yukio Sawaishi, et al.. (2002). Abnormal white matter lesions with sensorineural hearing loss caused by congenital cytomegalovirus infection: retrospective diagnosis by PCR using Guthrie cards. Brain and Development. 24(7). 710–714. 32 indexed citations
4.
Funato, Tadao, Noriyuki Satoh, Yu Abe, et al.. (2001). Quantitative PCR determination of human cytomegalovirus in blood cells. Journal of Clinical Laboratory Analysis. 15(3). 122–126. 7 indexed citations
5.
Funato, Tadao, et al.. (2001). Increased sensitivity to cytosine arabinoside in human leukemia by c-raf-1 antisense oligonucleotides. Anti-Cancer Drugs. 12(4). 325–329. 3 indexed citations
6.
Funato, Tadao, Hisayuki Yokoyama, Minami Yamada, et al.. (2001). Clonal evolution from trisomy into tetrasomy of chromosome 8 associated with the development of acute myeloid leukemia from myelodysplastic syndrome. Cancer Genetics and Cytogenetics. 124(2). 159–164. 10 indexed citations
7.
Suzuki, Yoko, Tadao Funato, Yasuhiko Munakata, et al.. (2000). Chemically Modified Ribozyme to V Gene Inhibits Anti-DNA Production and the Formation of Immune Deposits Caused by Lupus Lymphocytes. The Journal of Immunology. 165(10). 5900–5905. 6 indexed citations
9.
Uehara, S., et al.. (1999). SRY Mutation and Tumor Formation on the Gonads of XY Pure Gonadal Dysgenesis Patients. Cancer Genetics and Cytogenetics. 113(1). 78–84. 27 indexed citations
10.
Munakata, Yasuhiko, Atsushi Hoshino, Tai Muryoi, et al.. (1998). Somatic mutation in autoantibody-associated VH genes of circulating IgM+IgD+ B cells. European Journal of Immunology. 28(5). 1435–1444. 11 indexed citations
11.
Uehara, Shigeki, et al.. (1997). A Turner syndrome woman with a ring X chromosome [45,X/46,X,r(X)(p22.3q27)] whose child also had a ring X chromosome. Fertility and Sterility. 67(3). 576–579. 26 indexed citations
12.
Ioritani, Naomasa, Koichi Kambe, Masaaki Kuwahara, et al.. (1996). Microscope Opened by Shock Waves on Cancer Cell Surfaces : Morphological and Functional Features. 9(2). 161–167. 3 indexed citations
13.
Ohta, Y., Toshiya Shitara, Tadao Funato, et al.. (1994). H‐ras Ribozyme‐Mediated, Alteration of the Human Melanoma Phenotypea. Annals of the New York Academy of Sciences. 716(1). 242–256. 23 indexed citations
14.
Fodstad, Øystein, Viví Ann Flørenes, Mohammed Kashani‐Sabet, et al.. (1993). Effect of an anti-ras ribozyme on tumor cell phenotype. Melanoma Research. 3(1). 67–67. 1 indexed citations
15.
Funato, Tadao, et al.. (1992). The utility of an antifos ribozyme in reversing cisplatin resistance in human carcinomas. Advances in Enzyme Regulation. 32. 195–209. 43 indexed citations
16.
Kashani–Sabet, Mohammed, Tadao Funato, T Tone, et al.. (1992). Reversal of the Malignant Phenotype by an Anti- ras Ribozyme. PubMed. 2(1). 3–15. 92 indexed citations
17.
Scanlon, Kevin J., Mohammed Kashani–Sabet, T Tone, & Tadao Funato. (1991). Cisplatin resistance in human cancers. Pharmacology & Therapeutics. 52(3). 385–406. 82 indexed citations
18.
Scanlon, Kevin J., et al.. (1990). Potentiation of Azidothymidine Cytotoxicity in Cisplatin-resistant Human Ovarian Carcinoma Cells. PubMed. 2(10). 339–343. 20 indexed citations
19.
Katayama, Ichiro, et al.. (1989). A Trichilemmoma Cell Line Can Generate Interleukin-1-Alpha. Dermatology. 179(Suppl. 1). 135–136. 1 indexed citations
20.
Kubo, K., et al.. (1988). An autopsy case of malignant pleural mesothelioma with eosinophilia and gastric wall metastasis.. Haigan. 28(4). 521–528. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026